Cargando…
Osteogenic Programming of Human Mesenchymal Stem Cells with Highly Efficient Intracellular Delivery of RUNX2
Mesenchymal stem cells (MSCs) are being exploited in regenerative medicine due to their tri‐lineage differentiation and immunomodulation activity. Currently, there are two major challenges when directing the differentiation of MSCs for therapeutic applications. First, chemical and growth factor stra...
Autores principales: | Thiagarajan, Lalitha, Abu‐Awwad, Hosam Al‐Deen M., Dixon, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702512/ https://www.ncbi.nlm.nih.gov/pubmed/29090533 http://dx.doi.org/10.1002/sctm.17-0137 |
Ejemplares similares
-
Genetically-programmed, mesenchymal stromal cell-laden & mechanically strong 3D bioprinted scaffolds for bone repair
por: Abu Awwad, Hosam Al-Deen M., et al.
Publicado: (2020) -
Resveratrol Mediated Modulation of Sirt-1/Runx2 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells: Potential Role of Runx2 Deacetylation
por: Shakibaei, Mehdi, et al.
Publicado: (2012) -
Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis
por: Roos, Alison, et al.
Publicado: (2015) -
Mesenchymal Stem Cell Spheroids Retain Osteogenic Phenotype Through α(2)β(1) Signaling
por: Murphy, Kaitlin C., et al.
Publicado: (2016) -
miR-488 negatively regulates osteogenic differentiation of bone marrow mesenchymal stem cells induced by psoralen by targeting Runx2
por: Huang, Yongquan, et al.
Publicado: (2019)